PFM Health Sciences, LP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
PFM Health Sciences, LP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2022$5,711,334
-33.5%
130,3660.0%0.20%
-34.1%
Q3 2022$8,590,000
-68.2%
130,366
-61.3%
0.31%
-75.8%
Q4 2019$26,981,000
-65.0%
336,800
-65.1%
1.28%
-24.7%
Q1 2019$77,174,000
-2.6%
964,075
-34.4%
1.71%
-19.0%
Q4 2018$79,271,000
-29.5%
1,470,436
+2.1%
2.11%
+27.9%
Q3 2018$112,409,000
+109.8%
1,440,038
+70.6%
1.65%
+96.3%
Q2 2018$53,582,000
-36.3%
844,081
-8.1%
0.84%
-50.9%
Q1 2018$84,180,000
+28.8%
917,990
+5.9%
1.71%
+10.3%
Q4 2017$65,361,000
-42.4%
866,740
-46.8%
1.55%
-30.5%
Q3 2017$113,498,000
+74.1%
1,629,086
+26.6%
2.23%
+27.0%
Q2 2017$65,184,000
+54.9%
1,286,450
+22.3%
1.76%
+66.8%
Q1 2017$42,070,000
+87.5%
1,052,012
+31.5%
1.05%
+66.6%
Q4 2016$22,439,000
+36.6%
799,951
+44.6%
0.63%
+31.4%
Q3 2016$16,427,000
-50.7%
553,085
-66.4%
0.48%
-52.2%
Q2 2016$33,342,000
+30.0%
1,646,516
+15.9%
1.01%
+27.2%
Q1 2016$25,640,000
-3.5%
1,420,511
+40.9%
0.79%
-2.0%
Q4 2015$26,557,000
+26.3%
1,008,232
-1.9%
0.81%
+36.3%
Q3 2015$21,030,000
+0.5%
1,027,553
+19.2%
0.59%
+11.7%
Q2 2015$20,916,000862,1650.53%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders